Semaglutide – 5mg

$80.00

-27%Limited
Add to cart
Semaglutide - 5mg research peptide vial
Semaglutide 5mg peptide research vial
Semaglutide – 5mg $80.00

Semaglutide – 5mg is a GLP-1 receptor agonist studied for glycemic control, weight loss, cardiovascular protection, and potential benefits in NAFLD and neuroprotection.

SALE!
Up to 9%
Bacteriostatic Water – 10ml $7.00

Bacteriostatic Water – 10ml is a sterile, multi-use diluent designed for research purposes, commonly used to reconstitute peptides and compounds in laboratory settings.

-17%Limited
Add to cart
Retatrutide 5mg research peptide vial
Retatrutide 5mg research peptide vial
Retatrutide – 5mg $95.00

Retatrutide – 5mg is a synthetic peptide studied for its potential effects on glucose metabolism, weight management, cardiovascular health, and inflammation.

-20%Limited
Add to cart
Tirzepatide 5mg peptide research vial
Tirzepatide 5mg peptide research vial
Tirzepatide – 5mg GLP-1 $80.00

Tirzepatide – 5mg is a dual GIP and GLP-1 receptor agonist peptide designed for research. Investigate its role in glucose metabolism, insulin sensitivity, and fat loss potential.

           
Total: $262.00

Semaglutide – 5mg | Research Peptide for Metabolic Studies

body {
font-family: ‘Lato’, sans-serif;
color: #333;
line-height: 1.8;
margin: 0;
padding: 0;
}
h1 {
font-family: ‘Montserrat’, sans-serif;
font-size: 36px;
font-weight: bold;
text-align: center;
color: #1e93a7;
}
h2 {
font-family: ‘Montserrat’, sans-serif;
font-size: 24px;
font-weight: 600;
color: #1e93a7;
}
h3 {
font-family: ‘Montserrat’, sans-serif;
font-size: 18px;
font-weight: 600;
color: #1e93a7;
}
.highlight {
background-color: #e6f7f8;
border: 1px solid #BCE0E3;
padding: 20px;
border-radius: 8px;
margin-bottom: 20px;
}
.disclaimer {
font-size: 12px;
color: #555;
text-align: center;
background-color: #f7f9fa;
border: 1px solid #E0E6EA;
padding: 15px;
border-radius: 8px;
}
.references {
font-family: ‘Lato’, sans-serif;
font-size: 14px;
color: #1e93a7;
line-height: 1.8;
}

Semaglutide – 5mg

Semaglutide – 5mg is a synthetic GLP-1 receptor agonist widely studied for its effects on glycemic control, weight loss, cardiovascular health, and liver function. By mimicking the effects of GLP-1, Semaglutide offers a unique research pathway into metabolic and cardiovascular health.

Chemical Information

  • Chemical Formula: C₁₈₇H₂₁₅N₃₃O₅₁
  • Molecular Mass: 4113.57 g/mol
  • Synonyms: Ozempic, Wegovy, GLP-1 Receptor Agonist
  • CAS Number: 910463-68-2
  • PubChem ID: 56843321
  • Total Amount: 5 mg
  • Shelf Life: 2 years when stored at -20°C

What is Semaglutide?

Semaglutide is a GLP-1 receptor agonist that mimics the activity of glucagon-like peptide-1 (GLP-1), a hormone involved in blood sugar regulation. It has been widely studied for its role in improving glycemic control, promoting weight loss, and offering cardiovascular and liver health benefits.

Research Applications of Semaglutide – 5mg

1. Glycemic Control

Semaglutide enhances insulin secretion in response to elevated blood glucose levels while suppressing glucagon release. This dual action reduces HbA1c levels and supports diabetes research [1].

2. Weight Loss

Semaglutide suppresses appetite, delays gastric emptying, and reduces caloric intake, making it a focus of research on obesity and weight management [2].

3. Cardiovascular Protection

Studies show Semaglutide reduces the risk of major cardiovascular events in individuals with Type 2 Diabetes. Its effects on lipid profiles and inflammation are of interest in cardiovascular research [3].

4. Neuroprotective Effects

Semaglutide has demonstrated potential in supporting brain health in research models. Ongoing studies explore its ability to reduce neuroinflammation and its potential impact on neurodegenerative diseases [4].

5. Liver Health

Semaglutide’s ability to reduce liver fat and inflammation makes it a promising candidate for research into non-alcoholic fatty liver disease (NAFLD) and non-alcoholic steatohepatitis (NASH) [5].

Warning: This product is for laboratory research purposes only. Not for human or animal use.

Scientific References

  1. Davies, M., et al. “Semaglutide Once Weekly for the Treatment of Type 2 Diabetes.” The New England Journal of Medicine, vol. 377, no. 7, 2017, pp. 644-657.
  2. Wilding, J.P.H., et al. “Once-Weekly Semaglutide in Adults with Overweight or Obesity.” The New England Journal of Medicine, vol. 384, no. 11, 2021, pp. 989-1002.
  3. Marso, S.P., et al. “Semaglutide and Cardiovascular Outcomes in Patients with Type 2 Diabetes.” The New England Journal of Medicine, vol. 375, no. 19, 2016, pp. 1834-1844.
  4. Holscher, C. “Protective Effects of GLP-1 Agonists in Neurodegenerative Diseases.” Lancet Neurology, vol. 13, no. 6, 2014, pp. 672-681.
  5. Armstrong, M.J., et al. “Semaglutide for the Treatment of Nonalcoholic Steatohepatitis: A Randomized, Controlled Trial.” New England Journal of Medicine, vol. 384, no. 12, 2021, pp. 1113-1124.

Based on 0 reviews

0.00 Overall
0%
0%
0%
0%
0%
Be the first to review “Semaglutide – 5mg”

Your email address will not be published. Required fields are marked *

Reviews

There are no reviews yet.

My Cart
Recently Viewed
Compare Products (0 Products)
Compare Product
Compare Product
Compare Product
Compare Product
Categories